Suppr超能文献

人纤溶酶原各种活化形式及其等摩尔链激酶复合物的酯酶和人纤溶酶原激活剂活性比较。

Comparison of the esterase and human plasminogen activator activities of various activated forms of human plasminogen and their equimolar streptokinase complexes.

作者信息

Wohl R C, Arzadon L, Summaria L, Robbins K C

出版信息

J Biol Chem. 1977 Feb 25;252(4):1141-7.

PMID:851483
Abstract

A comparison was made of the esterase and activator activities of the various activated forms of human plasminogen and their streptokinase complexes with Nalpha-Cbz-L-lysine-p-nitrophenyl ester as the substrate. The steady state kinetic properties of Glu- and Lys-plasmins, and Glu- and Lys-plasminogen-streptokinase complexes were identical, while the Lys-plasmin-streptokinase complex showed a 2-fold increase in Km with the same kcat and a 3-fold increase in Ki for the competitive inhibitor leupeptin. Lys-plasminogen (zymogen with an active site) was prepared which incorporated 0.7 mol of [3H]idisopropyl phosphorofluoridate and 0.43 mol of p-nitrophenyl-p'-guanidinobenzoate/mol of protein. The Km for Lys-plasminogen was 3-fold higher than that of Lys-plasmin, and its maximum velocity 10-fold lower. The steady state kinetic parameters of a plasmin-derived light (B) chain (CmCys)3, and a derived equimolar light (B) chain-streptokinase complex (CmCys)3, isolated from human plasmin and equimolar plasmin-streptokinase, or plasminogen-streptokinase, complexes, respectively, were determined. When the light (B) chain-streptokinase complex is isolated from its parent complexes, there is a complete retention of the original parent's esterase activities, with respect to Km and kcat, and interaction with the competitive inhibitors benzamidine and leupeptin. The plasmin-derived light (B) chain does not retain its parent esterase activities. This chain has very similar kinetic properties to Lys-plasminogen except that streptokinase, in an equal molar amount, does not impart full esterase activity to the light (B) chain whereas the zymogen can be completely activated by streptokinase. The kcat of the plasmin-derived light (B) chain, and its streptokinase complex can be enhanced by 50 and 30%, respectively, in the presence of 10(-4) M leupeptin, a competitive inhibitor of plasmin, attesting to the increased structural flexibility within the active site of this enzyme species. Urokinase hydrolyzes Nalpha-Cbz-L-lysine p-nitrophenyl ester efficiently with a kcat/Km of one-third that of plasmin. The human plasminogen activator activities of various activated forms of human plasminogen and their equimolar streptokinase complexes were compared in a kinetic assay. The Lys-plasmin-streptokinase complex, and streptokinase were the least active of the activator species and were approximately equal in their activator activities. Glu- and Lys-plasminogen-streptokinase complexes had approximately 1.5 times the activity of streptokinase, whereas the equimolar light (B) chain-streptokinase complexes had approximately 2- to 3-times the activator activity of streptokinase. Since the esterase activity remained unchanged, this indicates a greater degree of specificity in the active site of the equimolar light (B) chain-streptokinase activator complex. Urokinase proved to be a poor activator species...

摘要

以Nα - Cbz - L - 赖氨酸 - 对硝基苯酯为底物,对人纤溶酶原的各种活化形式及其与链激酶的复合物的酯酶和激活剂活性进行了比较。谷氨酸纤溶酶和赖氨酸纤溶酶、谷氨酸纤溶酶原 - 链激酶复合物和赖氨酸纤溶酶原 - 链激酶复合物的稳态动力学性质相同,而赖氨酸纤溶酶 - 链激酶复合物的Km增加了2倍,kcat相同,对竞争性抑制剂亮肽素的Ki增加了3倍。制备了掺入0.7摩尔[3H]二异丙基磷酰氟和0.43摩尔对硝基苯基 - p' - 胍基苯甲酸/摩尔蛋白质的赖氨酸纤溶酶原(具有活性位点的酶原)。赖氨酸纤溶酶原的Km比赖氨酸纤溶酶高3倍,其最大速度低10倍。分别从人纤溶酶和等摩尔纤溶酶 - 链激酶或纤溶酶原 - 链激酶复合物中分离出纤溶酶衍生的轻链(B链)(CmCys)3及其衍生的等摩尔轻链(B链) - 链激酶复合物(CmCys)3,并测定其稳态动力学参数。当从轻链(B链) - 链激酶复合物的母体复合物中分离出该复合物时,就Km和kcat而言,其完全保留了原始母体的酯酶活性,并且与竞争性抑制剂苯甲脒和亮肽素相互作用。纤溶酶衍生的轻链(B链)不保留其母体酯酶活性。该链具有与赖氨酸纤溶酶原非常相似的动力学性质,不同之处在于等摩尔量的链激酶不能赋予轻链(B链)完全的酯酶活性,而酶原可被链激酶完全激活。在纤溶酶的竞争性抑制剂10^(-4) M亮肽素存在下,纤溶酶衍生的轻链(B链)及其链激酶复合物的kcat可分别提高50%和30%,这证明了该酶活性位点内结构灵活性的增加。尿激酶以kcat/Km为纤溶酶的三分之一的效率水解Nα - Cbz - L - 赖氨酸对硝基苯酯。在动力学测定中比较了人纤溶酶原的各种活化形式及其等摩尔链激酶复合物的人纤溶酶原激活剂活性。赖氨酸纤溶酶 - 链激酶复合物和链激酶是激活剂种类中活性最低的,它们的激活剂活性大致相等。谷氨酸和赖氨酸纤溶酶原 - 链激酶复合物的活性约为链激酶的1.5倍,而等摩尔轻链(B链) - 链激酶复合物的激活剂活性约为链激酶的2至3倍。由于酯酶活性保持不变,这表明等摩尔轻链(B链) - 链激酶激活剂复合物的活性位点具有更高程度的特异性。尿激酶被证明是一种较差的激活剂种类……

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验